← Open Payments lookup

CAMI WICKSTROM: Open Payments

NPI 1255003273 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$562 in 15 payments from 10 companies in 2025. Trend: 2023 $249 · 2024 $135 · 2025 $562

Food & beverage: $562
CompanyPaymentsAmount
ABBVIE INC.4$161
AstraZeneca Pharmaceuticals LP1$120
Ardelyx, Inc.1$119
Sumitomo Pharma America, Inc.2$42
Lilly USA, LLC2$34
PFIZER INC.1$21
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Janssen Pharmaceuticals, Inc1$16
Novo Nordisk Inc1$15
Axsome Therapeutics, Inc.1$14

Products named: FASENRA, IBSRELA, QULIPTA, VRAYLAR, GEMTESA, JARDIANCE, VYNDAQEL, CAPLYTA.

Industry payments across NE — which companies pay providers there.